Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
Hindustan FoodsQ1 FY27Diversified FMCG
Home/Stocks/Hindustan Foods/Q1 FY27

Hindustan Foods Q1 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹626P/E: 48.3Market Cap: ₹7.8K CrSector: Diversified FMCG

Management growth scorecard

Revenue

N/A

Margin

N/A

Fundraise

N/A

Order

N/A

Capex

N/A

0 of 0 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

  • →Q1 FY '27 showed robust growth with the highest-ever quarterly PAT despite some cost pressures, indicating strong business momentum.
  • →The company expects to sustain growth driven by a diversified manufacturing platform, disciplined execution, and long-term strategies.
  • →Significant capex of INR340 crores in FY '27, adding new capacities, especially in food & beverages (INR210 cr), ice cream (INR80 cr), and home & personal care (INR50 cr).
  • →Pipeline projects worth about INR1,000 crores, though actual conversions depend on successful project signings.
  • →Continued leveraging internal accruals 1:1 to fund growth with targeted ROCE of 18%, avoiding external funding.
  • →Improved market dynamics and customer confidence, notably in the shoe business and core HPC categories, support optimistic volume growth.
  • →Full order books starting Q2 FY '27 enhance capacity utilization and revenue prospects.
  • →Overall, the company reaffirms FY '27 PAT guidance and expects sustainable, profitable growth ahead.

Margin guidance

  • →The company delivered its highest ever quarterly PAT in Q1 FY'27, with a 33% growth YoY, indicating strong profitability momentum.
  • →FY'27 PAT guidance is reaffirmed between INR 200 crores to INR 220 crores, representing a 34%-48% growth over FY'26.
  • →Robust growth expected, supported by increased utilization of recently commissioned capacities, healthy execution of project pipeline, and operating leverage.
  • →Investment of approximately INR 340 crores planned during FY'27 in new projects, with total capex exceeding INR 500 crores, signaling capacity expansion.
  • →Long-term growth drivers include strong structural tailwinds in India's contract manufacturing sector, a healthy project pipeline (~INR 1,000 crores), and deepening customer partnerships.
  • →Management aims to sustain threshold ROCEs of 18% and grow primarily through internal accruals without needing external funding.
  • →Focus on commercializing new capacities on schedule, improving asset utilization, prudent capital allocation, and consistently enhancing returns.

3 more insights locked — sign up free to unlock

Fundraise plans

  • →The company plans to grow by investing internally generated funds into productive assets, targeting threshold ROCEs of 18%.
  • →They expect to grow without needing to access outside funds.
  • →Internal accruals will be leveraged on a 1:1 debt-equity ratio basis for funding projects.
  • →Capex announcements are made only after projects are signed; a project pipeline of around INR 1,000 crores exists, but only confirmed projects are announced.
  • →There is no mention of any planned new fundraising through either debt or equity.
  • →The strategy emphasizes disciplined capital allocation and maintaining a balance between debt and equity.
  • →Overall, current indications suggest no immediate or planned equity or external debt fundraising.

Order book

  • →The company has a project pipeline worth approximately INR 1,000 crores, representing potential investments customers are looking at, although these are not confirmed orders.
  • →Capex announcements are made only after projects are formally signed; thus, the announced capex may be lower than pipeline value.
  • →Last year, the company invested about INR 500 crores and expects to invest more than INR 500 crores in FY '27, with a similar opening carryforward pipeline value for FY '28.
  • →The hit ratio (conversion rate from pipeline to orders) varies widely across customers and business units, making precise predictions difficult.
  • →The company remains focused on execution capabilities rather than just conversion ratios.
  • →Order book and capacities from Q2 FY '27 onwards are full for the rest of the financial year.
  • →New investments of INR 340 crores in FY '27 are authorized, across Food & Beverages, Ice Cream, and Home & Personal Care segments.

Capex plans

  • →The company has announced a total capex of INR 340 crores for FY '27, authorized by the Board.
  • →This includes new expansion projects: INR 210 crores for Food and Beverages (Coimbatore, Mysuru, Goa, Aurangabad, Hyderabad), INR 80 crores for Ice Cream at Panipat, and INR 50 crores for Home and Personal Care at Lucknow.
  • →This capex is in addition to INR 150 crores worth of projects carried forward from FY '26.
  • →The project pipeline is about INR 1,000 crores, reflecting strong customer interest, though only announced after signing.
  • →Expected investment about INR 500+ crores per year, maintaining a 1:1 debt-equity ratio.
  • →New capacities are expected to be commercialized on schedule with a focus on improving asset utilization.
  • →The beverage units (part of new projects) expected to come online by Dec-Jan to catch the season.
  • →The company plans to continue leveraging internal accruals for growth without needing outside funds.

How does Hindustan Foods rank vs peers in Diversified FMCG?

Pro feature
1Hindustan Foods
2Diversified FMCG Company A
Rev 1Mar 2
3Diversified FMCG Company B
Rev 2Mar 1
4Diversified FMCG Company C
Rev 2Mar 3

See full Diversified FMCG sector rankings

How does Hindustan Foods rank in Diversified FMCG?

Compare Hindustan Foods against every Diversified FMCG company (Q1 FY27) on revenue, margins and earnings-call signals.

View Diversified FMCG leaderboard →

Related research

Read the full Q1 FY27 earnings insight — Hindustan Foods

Other quarters — Hindustan Foods

Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24

Diversified FMCG peers

Hind. Unilever · Q1 FY27Godavari Bioref. · Q4 FY26
Hindustan Foods full stock analysisDiversified FMCG sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What Hindustan Foods's management said in earlier quarters

  • Q1 FY27 earnings call analysis →
  • Q3 FY26 earnings call analysis →
  • Q1 FY26 earnings call analysis →
  • Q4 FY26 earnings call analysis →

Others in Diversified FMCG this season

  • Hind. Unilever (Q1 FY27)

    Underlying Profit After Tax (adjusted for one-offs) grew 11% this quarter, reflecting confidence in profit growth trajectory. Key concall takeaways from Hind…

  • Godavari Bioref. (Q3 FY26)

    Continued cost optimization, improved product mix, and operating leverage led to a 13.8% EBITDA growth in Q3 FY26, with margins improving by 97 bps to 9.8%…

  • Hind. Unilever (Q3 FY26)

    The company is scaling its presence in fast-growing segments like Masstige and D2C channels, notably doubling down on brands like OZiva with full acquisition…

  • Godavari Bioref. (Q2 FY26)

    Early signs of recovery in Q2 FY26 with 34% YoY revenue growth and EBITDA losses narrowing significantly. Key concall takeaways from Godavari Bioref.'s Q2 FY26…

Compare:vs Hind. Unilevervs ITCvs Godavari Bioref.